Literature DB >> 33020334

Risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients: A systematic review.

Siti Setiati1, Kuntjoro Harimurti, Eka Dian Safitri, Respati W Ranakusuma, Siti Rizny F Saldi, Muhammad K Azwar, Jessica Marsigit, Yupitri Pitoyo, Widyaningsih Widyaningsih.   

Abstract

BackgroundWe aimed to systematically review all relevant studies related to the risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients.MethodsWe utilised PubMed, Scopus, ProQuest, Wiley Online Library, ScienceDirect and MedRxiv to search for studies, with additional hand-searched journals. We included systematic reviews/meta-analyses, cohort and case control studies of suspected and/or confirmed COVID-19 cases with severe illness and/or mortality as outcomes. We included laboratory test results and risk factors. We assessed risk of bias using ROBIS-I and Newcastle-Ottawa Scale assessment tool. Type of study, risk of bias, and precision of results determined evidence sufficiency.ResultsOf 26 records included, sufficient evidence suggested the association between age >60 years, hypertension, coronary heart disease, DM, serum LDH 250-500 U/L, LDH >500 U/L, and lymphopenia (lymphocyte count ≤1.0 x 109 /L) and severe illness of COVID-19. CD3+CD8+ cell count ≤ 75 cell/μl, D-dimer > 1 mg/L, AKI stage 2 and 3, proteinuria ≥1+, hematuria ≥1+, and peak serum creatinine > 13.26 μmol/L are associated with mortality.ConclusionAge >60 years, hypertension, DM, and coronary heart disease are the risk factors for severe illness of COVID-19. Laboratory test results associated with severe illness are serum LDH 250-500 U/L, LDH >500 U/L, and lymphopenia, whereas test results associated with mortality are CD3+CD8+ cell count ≤ 75 cell/μl, AKI stage 2 and 3, proteinuria ≥1+, hematuria ≥1+, D-dimer > 1 mg/L, peak serum creatinine > 13.26 μmol/L.

Entities:  

Keywords:  COVID-19; laboratory test; mortality; risk factor; severe illness

Mesh:

Year:  2020        PMID: 33020334

Source DB:  PubMed          Journal:  Acta Med Indones        ISSN: 0125-9326


  3 in total

1.  The age again in the eye of the COVID-19 storm: evidence-based decision making.

Authors:  María C Martín; Aurora Jurado; Cristina Abad-Molina; Antonio Orduña; Oscar Yarce; Ana M Navas; Vanesa Cunill; Danilo Escobar; Francisco Boix; Sergio Burillo-Sanz; María C Vegas-Sánchez; Yesenia Jiménez-de Las Pozas; Josefa Melero; Marta Aguilar; Oana Irina Sobieschi; Marcos López-Hoyos; Gonzalo Ocejo-Vinyals; David San Segundo; Delia Almeida; Silvia Medina; Luis Fernández; Esther Vergara; Bibiana Quirant; Eva Martínez-Cáceres; Marc Boiges; Marta Alonso; Laura Esparcia-Pinedo; Celia López-Sanz; Javier Muñoz-Vico; Serafín López-Palmero; Antonio Trujillo; Paula Álvarez; Álvaro Prada; David Monzón; Jesús Ontañón; Francisco M Marco; Sergio Mora; Ricardo Rojo; Gema González-Martínez; María T Martínez-Saavedra; Juana Gil-Herrera; Sergi Cantenys-Molina; Manuel Hernández; Janire Perurena-Prieto; Beatriz Rodríguez-Bayona; Alba Martínez; Esther Ocaña; Juan Molina
Journal:  Immun Ageing       Date:  2021-05-20       Impact factor: 6.400

2.  Serial Changes of Long COVID Symptoms and Clinical Utility of Serum Antibody Titers for Evaluation of Long COVID.

Authors:  Yasue Sakurada; Naruhiko Sunada; Hiroyuki Honda; Kazuki Tokumasu; Yuki Otsuka; Yasuhiro Nakano; Yoshihisa Hanayama; Masanori Furukawa; Hideharu Hagiya; Fumio Otsuka
Journal:  J Clin Med       Date:  2022-02-27       Impact factor: 4.241

Review 3.  The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens.

Authors:  Aristo Vojdani; Elroy Vojdani; Avi Z Rosenberg; Yehuda Shoenfeld
Journal:  Pathophysiology       Date:  2022-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.